---
title: "COVID-19 Vaccination Disclosures on Twitter: Themes, Timing, and Public Engagement"
id: "pubmed-43043654"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43043654"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43043654/"
doi: "10.2196/99837"
published_at: "2026-11-17T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# COVID-19 Vaccination Disclosures on Twitter: Themes, Timing, and Public Engagement
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43043654
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43043654/)
- **DOI:** [10.2196/99837](https://doi.org/10.2196%2F99837)
- **Published At:** 2026-11-17T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Investigators analyzed 207,647 first-person **vaccination** disclosure posts on **Twitter** (Dec 14, 2020–Jan 1, 2022) to map themes and engagement. - A RoBERTa classifier trained on 6,348 human-coded posts identified disclosure posts with an F1 score of 0.85, the study team reported. - Mixed deductive-inductive coding, grounded in the disclosure decision model (DDM), produced 11 thematic categories with Krippendorff α between 0.72 and 0.93. - Major themes included community identity (31,847 posts), encouraging others (29,619), and gratitude (29,511), each representing roughly 14–15% of the corpus. - Temporal patterns varied by rollout phase: gratitude dominated phase 1; community identity increased in phases 2 and 4; encouragement peaked in phase 3. - Negative binomial regression linked themes to engagement (likes, reposts, quotes, replies), adjusted for follower count, media, word count, sentiment, and other post-level covariates. - **Gratitude** and relief were associated with about a 25% higher engagement rate (IRRs 1.25 and 1.26 respectively); community identity raised engagement by ~19% (IRR=1.19), authors noted. - Posts mentioning side effects, politics, or social benefits were associated with lower engagement (IRRs 0.85, 0.90, 0.92 respectively), according to the reported models. - Each additional disclosure theme in a post increased engagement by approximately 7% (IRR=1.07). - Network analysis evaluated co-occurrence of themes across the four rollout phases; the source did not report finer-grained methodological parameters beyond this summary. - Authors argued that identity-based and emotionally resonant disclosures may inform peer-based communication strategies for future immunization campaigns.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43043654/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043654%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43043654/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43043654/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43043654/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43043654/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43043654/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43043654/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043654%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043654%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43043654/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43043654/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43043654/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43043654/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43043654/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43043654/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43043654/#abstract) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43043654/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43043654/#substances) Title & authors Abstract MeSH terms Substances J Med Internet Res Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Med+Internet+Res%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Med+Internet+Res%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) . 2026 Nov 17:28:e99837. doi: 10.2196/99837. # Themes, Temporal Dynamics, and Public Engagement in COVID-19 Vaccination Disclosures on Twitter: Computational Content Analysis [Emily McKinley](https://pubmed.ncbi.nlm.nih.gov/?term=McKinley+E&cauthor_id=43043654)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43043654/#full-view-affiliation-1 "Department of Communication, University of California, Davis, 469 Kerr Hall, One Shields Avenue, Davis, CA, 95616-5270, United States, 1 530-752-0966."), [Cuihua Shen](https://pubmed.ncbi.nlm.nih.gov/?term=Shen+C&cauthor_id=43043654)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43043654/#full-view-affiliation-1 "Department of Communication, University of California, Davis, 469 Kerr Hall, One Shields Avenue, Davis, CA, 95616-5270, United States, 1 530-752-0966."), [Kenji Sagae](https://pubmed.ncbi.nlm.nih.gov/?term=Sagae+K&cauthor_id=43043654)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43043654/#full-view-affiliation-2 "Department of Linguistics, University of California, Davis, Davis, CA, United States."), [Jingwen Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+J&cauthor_id=43043654)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43043654/#full-view-affiliation-1 "Department of Communication, University of California, Davis, 469 Kerr Hall, One Shields Avenue, Davis, CA, 95616-5270, United States, 1 530-752-0966.") Affiliations Expand ### Affiliations * 1 Department of Communication, University of California, Davis, 469 Kerr Hall, One Shields Avenue, Davis, CA, 95616-5270, United States, 1 530-752-0966. * 2 Department of Linguistics, University of California, Davis, Davis, CA, United States. * PMID: **43043654** * DOI: [ 10.2196/99837 ](https://doi.org/10.2196/99837) Item in Clipboard # Themes, Temporal Dynamics, and Public Engagement in COVID-19 Vaccination Disclosures on Twitter: Computational Content Analysis Emily McKinley et al. J Med Internet Res. 2026. Show details Display options Display options Format Abstract PubMed PMID J Med Internet Res Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Med+Internet+Res%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Med+Internet+Res%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) . 2026 Nov 17:28:e99837. doi: 10.2196/99837. ### Authors [Emily McKinley](https://pubmed.ncbi.nlm.nih.gov/?term=McKinley+E&cauthor_id=43043654)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43043654/#short-view-affiliation-1 "Department of Communication, University of California, Davis, 469 Kerr Hall, One Shields Avenue, Davis, CA, 95616-5270, United States, 1 530-752-0966."), [Cuihua Shen](https://pubmed.ncbi.nlm.nih.gov/?term=Shen+C&cauthor_id=43043654)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43043654/#short-view-affiliation-1 "Department of Communication, University of California, Davis, 469 Kerr Hall, One Shields Avenue, Davis, CA, 95616-5270, United States, 1 530-752-0966."), [Kenji Sagae](https://pubmed.ncbi.nlm.nih.gov/?term=Sagae+K&cauthor_id=43043654)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43043654/#short-view-affiliation-2 "Department of Linguistics, University of California, Davis, Davis, CA, United States."), [Jingwen Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+J&cauthor_id=43043654)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43043654/#short-view-affiliation-1 "Department of Communication, University of California, Davis, 469 Kerr Hall, One Shields Avenue, Davis, CA, 95616-5270, United States, 1 530-752-0966.") ### Affiliations * 1 Department of Communication, University of California, Davis, 469 Kerr Hall, One Shields Avenue, Davis, CA, 95616-5270, United States, 1 530-752-0966. * 2 Department of Linguistics, University of California, Davis, Davis, CA, United States. * PMID: **43043654** * DOI: [ 10.2196/99837 ](https://doi.org/10.2196/99837) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Background:** Social media has become a primary infrastructure for vaccine communication. Personal vaccination disclosures, or first-person announcements of vaccination decisions shared publicly online, represent an underexamined channel through which peer influence may shape vaccine attitudes and behavior. Understanding what individuals disclose when they announce vaccination, and how those disclosures evolve over time, offers actionable insights for designing peer-based communication strategies in future health emergencies. **Objective:** This study aimed to identify the themes present in COVID-19 vaccination disclosures on Twitter (rebranded as X in 2023), examine how those themes changed across 4 phases of the US vaccine rollout, and determine which themes were associated with greater public engagement. **Methods:** Guided by the disclosure decision model (DDM), we analyzed 207,647 vaccination disclosure posts on Twitter from December 14, 2020, to January 1, 2022. Posts were identified using a robustly optimized BERT pretraining approach (RoBERTa) binary classifier (_F_ 1-score=0.85) trained on 6348 human-coded posts. A mixed deductive-inductive coding approach, grounded in the DDM's motivational goals, yielded 11 disclosure themes (Krippendorff _α_ =0.72-0.93). Eleven additional RoBERTa classifiers were trained to label themes across the full dataset. Network analysis examined co-occurrence of themes within each rollout phase. Negative binomial regression assessed the association between disclosure themes and an engagement metric (sum of likes, reposts, quotes, and replies), controlling for follower count, media presence, word count, sentiment, and other post-level factors. **Results:** Eleven distinct disclosure themes were identified, including community identity (n=31,847, 15.34%), encouraging others (n=29,619, 14.26%), and gratitude (n=29,511, 14.21%). Themes shifted meaningfully across rollout phases: gratitude dominated phase 1, community identity rose in phases 2 and 4, and encouraging vaccination became prominent in phase 3. Gratitude was associated with a 25% increase in engagement (incidence rate ratio [IRR]=1.25; 95% CI 1.23-1.28; _P_ <.001), alongside relief (IRR=1.26; 95% CI 1.19-1.33; _P_ <.001) and community identity (IRR=1.19; 95% CI 1.17-1.21; _P_ <.001). Side effects (IRR=0.85; 95% CI 0.83-0.87; _P_ <.001), political (IRR=0.90; 95% CI 0.87-0.94; _P_ <.001), and social benefits disclosures (IRR=0.92; 95% CI 0.90-0.95; _P_ <.001) were associated with decreased engagement. Each additional theme in a post was associated with a 7% increase in engagement (IRR=1.07; 95% CI 1.06-1.08; _P_ <.001). **Conclusions:** Vaccination disclosures on Twitter were thematically patterned, theoretically interpretable via the DDM, and responsive to changing public health contexts. Identity-based and emotionally resonant disclosures, particularly gratitude and community identity, were among the themes most strongly associated with public engagement. These findings provide an empirically grounded framework for designing peer-based vaccine communication strategies that leverage voluntary self-disclosure in future immunization campaigns. **Keywords:** COVID-19; disclosure; network analysis; self-disclosure; semantic network analysis; social media; vaccination; vaccine disclosure; vaccines. © Emily McKinley, Cuihua Shen, Kenji Sagae, Jingwen Zhang. Originally published in the Journal of Medical Internet Research (https://www.jmir.org). [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## MeSH terms * COVID-19 Vaccines* / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22COVID-19+Vaccines%2Fadministration+and+dosage%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=COVID-19+Vaccines) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) * COVID-19* / prevention & control Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22COVID-19%2Fprevention+and+control%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=COVID-19) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) * Disclosure* Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Disclosure%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Disclosure) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) * SARS-CoV-2 Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22SARS-CoV-2%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=SARS-CoV-2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) * Social Media* Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Social+Media%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Social+Media) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) * Vaccination* Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Vaccination%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Vaccination) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) ## Substances * COVID-19 Vaccines Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22COVID-19+Vaccines%22%5Bnm%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=%22COVID-19+Vaccines%22) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43043654/) [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/43043654/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043654%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/43043654/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043654%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43043654%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/43043654/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323) [Web Policies](https://www.nlm.nih.gov/web_policies.html) [FOIA](https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office) [HHS Vulnerability Disclosure](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Help](https://support.nlm.nih.gov/?pagename=pubmed%3Apubmed%3Aabstract%3ANONE) [Accessibility](https://www.nlm.nih.gov/accessibility.html) [Careers](https://www.nlm.nih.gov/careers/careers.html) * [NLM](https://www.nlm.nih.gov/) * [NIH](https://www.nih.gov/) * [HHS](https://www.hhs.gov/) * [USA.gov](https://www.usa.gov/)
## Related Clinical Research

- [Big Pharma: AI halves early drug-discovery timelines; companies avoid Xinjiang trial sites](https://medichelpline.com/clinical-feed/stat-news-0-stat-pharmalittle-we-re-reading-about-sanofi-eyeing-insmed-ai-speeding-drug.md)
- [Hims and Noom bring experimental peptides to mainstream telehealth](https://medichelpline.com/clinical-feed/stat-news-1-stat-peptide-market-poised-to-explode-with-new-hims-and-noom-launches.md)
- [Real-World Safety of Nirmatrelvir Plus Ritonavir for COVID-19 in Japan: Post-Marketing Surveillance](https://medichelpline.com/clinical-feed/pubmed-41621946.md) (DOI: 10.7883/yoken.JJID.2024.380)
- [FDA Launches Global Reliance Disclosure Program to Enhance Access to Medicines](https://medichelpline.com/clinical-feed/fda-news-releases-0-fda-launches-the-global-reliance-disclosure-program-to-expand-patient-access-to.md)
- [Glove stewardship framework to apply WHO and CDC glove-use guidance after COVID-19](https://medichelpline.com/clinical-feed/pubmed-43038412.md) (DOI: 10.1097/NSG.0000000000000494)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.